Since targeting both normal and mutant HTT alleles might be toxic, considering crucial physiological role of HTT and the fact that a majority of HD gene carriers are heterozygous, new approaches aims at optimizing ASO and other tools to specifically target the mutant allele, and preserving the wild type HTT gene. Here, HTT is linked to Huntington disease.